4/A: NeonC Technologies Director Alan Chiang Reports Transactions in Company Stock

Director Alan Chiang reports multiple transactions involving NeonC Technologies Holdings, Inc. stock, including acquisitions, disposals, and warrant exercises, both directly and indirectly through related entities.

Summary

• Director Alan Chiang reported several transactions related to NeonC Technologies Holdings, Inc. common stock on March 26, 2025.
• These transactions include the acquisition of 50,000 shares of restricted common stock granted under the company's 2023 Equity Incentive Plan, which vest seven months after the initial listing date.
• Chiang also reported indirect transactions through HCWG LLC, including a transfer of 5,994 shares and the exercise of a warrant to purchase 312,500 shares at $12 per share.
• The warrant exercise resulted in the company withholding 150,000 shares to cover the exercise price and issuing 162,500 shares to HCWG.
• Additionally, Chiang reported disposals of shares held by HCWG LLC at prices of $25 and $19.1299.
• Chiang also reported beneficial ownership through Orion Biomed Inc. and NeuCen Biomedical Co. Ltd., disclaiming beneficial ownership except to the extent of his pecuniary interest.
• Following these transactions, Chiang directly owns 390,216 shares and indirectly owns shares through HCWG LLC (384,180), Orion Biomed Inc. (29,309), and NeuCen Biomedical Co. Ltd. (888,148).

Sentiment

Score: 6

Explanation: The sentiment is neutral. The document primarily reports transactions, with some positive aspects like the warrant exercise balanced by potential concerns about share disposals. The grant of restricted stock is a positive sign.

Positives

• The grant of restricted stock to the director aligns his interests with the company's success post-listing.
• The warrant exercise by HCWG LLC demonstrates confidence in the company's prospects.

Negatives

• The disposal of shares by HCWG LLC, even if part of a planned strategy, could be perceived negatively by the market.

Risks

• The director's indirect ownership through multiple entities adds complexity to the ownership structure.
• Fluctuations in the stock price could impact the value of the director's holdings and potentially influence future transactions.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting of restricted stock seven months after the initial listing suggests a continued involvement and alignment of interests of the director with the company's performance.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders. The transactions reported here are specific to NeonC Technologies and its director.

Related Party Transactions

• Transactions involving HCWG LLC, Orion Biomed Inc., and NeuCen Biomedical Co. Ltd., entities in which the reporting person has an interest, are considered related party transactions.

Stakeholder Impact

• The reported transactions could influence investor perception of the company's stock.
• The vesting of restricted stock aligns the director's interests with those of shareholders.

Key Dates

Keywords

NeonC Technologies, Director, Alan Chiang, Stock Transactions, Beneficial Ownership, Form 4, Equity Incentive Plan, Warrant Exercise, HCWG LLC, Orion Biomed Inc., NeuCen Biomedical Co. Ltd.